LES DROGUES

Althoug there has recently Been A Certain amount of debate over what the standard of care in screening asymptomatic Should Be for Prostate Cancer Patients evil one factor remains constant: if the result of a screening test is abnormal the patient needs to be informed of the results and Advised about the options for diagnostic testing, Such as a biopsy.

Should fail to give the doctor know the patient's prostate cancer spread and metastasize May Become thereby incurable before the patient is finally diagnosed and Becomes Symptomatic. That patient and his family in May have to diagnose medical malpractice claim failure Against the doctor.

The digital examination of the prostate gland is one of the two tests routinely used to screen men for prostate cancer. The presence of a nodule on the gland or hardened area is an abnormal finding indicated Cancer That Could. Below are three examples of cases Involving Abnormal Findings on a digital examination:

Case 1:

Involved in this case 73 year old patient ill Whose PCP (primary care physician). Even though the patient did not have prostate cancer Any Symptoms of the CFP Correctly performed the appropriate screening tests. The PSA blood test and ordered PPCPs performed a digital examination. The blood tests abnormally high levels of PSA Showed. The digital examination Revealed That the patient's prostate was enlarged. Two signs Pointed Toward the Possibility That the patient HAD prostate cancer.

Yet, the CFP His patient did not inform That the results of the blood test and digital examination Were the abnormal and suspicious for cancer. The CFP likewise did not order Any follow-up tests to rule out prostate cancer. By the time the patient was finally diagnosed the cancer metastasized to the bone HAD. That the law firm handled this case Reported That They Were Able to Achieve a recovery of $ 591.000 On behalf of the patient.

Case 2:

This case Involved an internist who was seen by a patient complaining of urinary problems. The internist performed a digital examination and Noted That the patient's prostate gland was enlarged. The internist then ordered a biopsy. This is the standard When there is an abnormal finding on the digital examination. The biopsy was performed at a local hospital. The Pathologist who Examined the biopsy samples Documented in a written report That the samples contained prostate cancer. It Took A Year Before The results Were not Communicated to the patient. The delay allowed the cancer to spread. Eventually it Took The patient's life. That this law firm handled the case reported the matter That settled prior to trial for a confidential amount.

As Both Of These cases Demonstrate it is not enough to Comply with screening guidelines. Doctors must follow up the results of screening tests When I come back as abnormal. Not doing so puts the patient at risk in the fact That he does have prostate cancer and the cancer will grow and That spreads to the point where it metastasizes and is No Longer curable. If That Happens That the best treatment can do is to slow down the spread of the cancer and to minimize the effects Eventually (Such as pain) of the cancer. Likely to fully preventable if the doctor follows up on the abnormal screening test results.

Thus a doctor who does not follow up when, for example, a digital examination catches the presence of a nodule or hardened area on a patient's prostate gland for medical malpractice May Be liable.

Joseph Hernandez is an Attorney focused on catastrophic injury and medical malpractice cases. His visit website to learn more about metastatic prostate cancer cases visit His website at http://www.prostatecancerlaw.com .

Article Source: Not Following Up On Prostate Examination Abnormal Can Result In A Medical Malpractice Claim